intrexon

@Intrexon

We are a community of scientists and creative innovators working to build a safer, healthier planet, and a more promising future. (NASDAQ: )

Vrijeme pridruživanja: travanj 2014.

Medijski sadržaj

  1. 3. velj

    completes series of transactions to solidify healthcare focus. Name changes to from and ticker symbol to :

  2. 15. sij

    Triple-Gene to highlight its investigational in Phase 1 for treatment of at TODAY January 15th at 11:30am PT in Franciscan B at the Hilton San Francisco Union Square

  3. 14. sij

    At ? Listen to Dr. Helen Sabzevari, President & CEO of , at 5pm PT in California West present on progress and 2020 look ahead OR watch live webcast here:

  4. 9. sij

    Triple-Gene to highlight advantages of its multigenic approach for treatment of at on January 15th, 2020 at 11:30AM PT at the Hilton San Francisco Union Square. Read more here:

  5. 7. stu 2019.

    Intrexon subsidiary Triple-Gene announces completion of dosing in Phase 1 trial of INXN-4001, first multigenic investigational candidate for treatment of . Learn more here:

  6. 4. stu 2019.

    to Announce Third Quarter Financial Results on Nov 12th. to host conference call that day at 11am ET to provide Precigen business and pipeline updates. To learn more and register, click here:

  7. 23. lis 2019.

    At ? Don’t miss Therapeutics™ CEO Pieter Rottiers presenting an overview of the innovative ActoBiotics® platform today Wednesday October 23 @ 9:15 AM PT. Read more: or follow us on LinkedIn or Twitter

  8. 1. lis 2019.

    At ? Don't miss Therapeutics™ CEO Pieter Rottiers' presentation at 4PM today about the innovative ActoBiotics® platform. More: or follow on Twitter or LinkedIn.

  9. 26. ruj 2019.

    David Witte formerly of to lead MBP Titan LLC, standalone subsidiary company of Intrexon comprising Intrexon’s Platform. Discover more: .

  10. 3. ruj 2019.

    Thrilled to be invited to kickoff the first annual conference. For more details, click here: Hope to see you there.

  11. 19. kol 2019.

    Breaking: Receives IND Green Light for New Antigen-Specific Study Aimed at Improving Celiac Patients' Tolerance of . is an under-served market with 0 approved pharmacological therapies. Discover more: -

  12. 5. kol 2019.

    Breaking News: Announces First Patient Dosed in Phase 1 Study of PRGN-3005 -T in Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal . Discover more:

  13. 1. kol 2019.

    Mark your calendar: to Announce Second Quarter and First Half 2019 Financial Results on Aug 8th. Conference call to be held that day at 5:30 PM ET to discuss the results and provide a general business update. To learn more and register, click here:

  14. 11. srp 2019.
  15. 26. lip 2019.

    highlighted in the latest podcast reaching 3M+ listeners on the heels of being honored by for its work in using biotechnology to turn mosquitoes into allies in the fight against malaria. Listen now and share:

  16. 18. lip 2019.

    Breaking News: Intrexon ($XON) and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based Production. Discover more: . Please share/RT

  17. 6. lip 2019.

    President Helen Sabzevari explains “we reduced the manufacturing to overnight” during Immuno-oncology: Taking to the Next Level panel.

  18. 5. lip 2019.

    Reminder: Helen Sabzevari, PhD, President of , will participate in the panel "Immuno-Oncology: Taking to the Next Level" on June 6th from 10:30 am-12:00 pm ET. Over 250+ people pre-registered so make sure you come early! – mjesto: Pennsylvania Convention Center

  19. 4. lip 2019.

    Packed house learning about - if you are at - come see us at booth 1313. We have a gift waiting for you, and it’s not just knowledge! – mjesto: Pennsylvania Convention Center

  20. 3. lip 2019.

    On the heels of announcements made this morning, exciting to hear RJ Kirk articulate Intrexon’s One Health mission. A lot of excitement in the air. – mjesto: Pennsylvania Convention Center

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·